Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials (Q37989790)
Jump to navigation
Jump to search
scientific article published on March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials |
scientific article published on March 2012 |
Statements
1 reference
Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials (English)
1 reference
Bernard Combe
1 reference
Pierre LE Blay
1 reference
Gael Mouterde
1 reference
Thomas Barnetche
1 reference
Jacques Morel
1 reference
1 March 2012
1 reference
1 reference
39
1 reference
4
1 reference
712-715
1 reference
Identifiers
1 reference
1 reference